Myomo (MYO) Capital Expenditures (QoQ) (2017 - 2025)
Myomo (MYO) Capital Expenditures (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -16.26% |
| Jun 30, 2025 | 87.47% |
| Mar 31, 2025 | -22.04% |
| Dec 31, 2024 | 168.24% |
| Sep 30, 2024 | 168.68% |
| Jun 30, 2024 | 99.58% |
| Mar 31, 2024 | 88.88% |
| Dec 31, 2023 | -41.46% |
| Sep 30, 2023 | 261.27% |
| Jun 30, 2023 | -66.79% |
| Mar 31, 2023 | 1,231.91% |
| Dec 31, 2022 | -40.99% |
| Sep 30, 2022 | -89.13% |
| Jun 30, 2022 | 5.84% |
| Mar 31, 2022 | 108.39% |
| Dec 31, 2021 | -56.39% |
| Sep 30, 2021 | -72.98% |
| Jun 30, 2021 | 356.64% |
| Mar 31, 2021 | 187.81% |
| Dec 31, 2020 | -31.04% |